# MEDICAL WRITING CONSULTING SERVICES

> **NIH NIH N02** · CCS ASSOCIATES, INC. · 2024 · $27,295

## Abstract

The NIH is seeking senior-level, industry-experienced drug discovery and development consultants with expertise in the following specific disciplines to provide leadership and technical guidance on drug discovery and development projects in the ultra-rare gene-based therapy (URGENT) program. The area of expertise needed in medical writing.

## Key facts

- **NIH application ID:** 11199800
- **Project number:** 75N95023P00692-P00001-0-2
- **Recipient organization:** CCS ASSOCIATES, INC.
- **Principal Investigator:** Caroline C Sigman
- **Activity code:** N02 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $27,295
- **Award type:** —
- **Project period:** 2023-09-14 → 2025-09-13

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11199800

## Citation

> US National Institutes of Health, RePORTER application 11199800, MEDICAL WRITING CONSULTING SERVICES (75N95023P00692-P00001-0-2). Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/grant/nih/11199800. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*